• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向金属口袋发现具有抗肺纤维化作用的选择性 PDE1 抑制剂。

Discovery of Selective PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects by Targeting the Metal Pocket.

机构信息

State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.

School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan 528458, China.

出版信息

J Med Chem. 2024 Nov 28;67(22):20203-20213. doi: 10.1021/acs.jmedchem.4c01533. Epub 2024 Nov 15.

DOI:10.1021/acs.jmedchem.4c01533
PMID:39546471
Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with no ideal drugs. Our previous research demonstrated that phosphodiesterase 1 (PDE1) could be a promising target for the treatment of IPF. However, only a few selective PDE1 inhibitors are available, and the mechanism of recognition between inhibitors and the PDE1 protein is not fully understood. This study carried out a step-by-step optimization of a dihydropyrimidine hit . By targeting the metal pocket of PDE1, a lead compound was obtained, exhibiting an IC value of 11 nM against PDE1, moderate selectivity over other PDEs, and significant anti-fibrotic effects in bleomycin-induced pulmonary fibrosis rats. The structure-activity relationship study aided by molecular docking revealed that forming halogen bonds with water in the metal pocket greatly enhanced the PDE1 inhibition, providing a novel strategy for further rational design of PDE1 inhibitors.

摘要

特发性肺纤维化(IPF)是一种致命的肺部疾病,目前尚无理想的药物。我们之前的研究表明,磷酸二酯酶 1(PDE1)可能是治疗 IPF 的一个有前途的靶点。然而,目前只有少数几种选择性 PDE1 抑制剂可用,并且抑制剂与 PDE1 蛋白之间的识别机制尚不完全清楚。本研究对二氢嘧啶类化合物进行了逐步优化。通过靶向 PDE1 的金属口袋,获得了一个先导化合物 ,对 PDE1 的 IC 值为 11 nM,对其他 PDE 具有中等选择性,并且在博来霉素诱导的肺纤维化大鼠中具有显著的抗纤维化作用。分子对接辅助的构效关系研究表明,与金属口袋中的水形成卤键可显著增强 PDE1 的抑制作用,为进一步合理设计 PDE1 抑制剂提供了一种新策略。

相似文献

1
Discovery of Selective PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects by Targeting the Metal Pocket.靶向金属口袋发现具有抗肺纤维化作用的选择性 PDE1 抑制剂。
J Med Chem. 2024 Nov 28;67(22):20203-20213. doi: 10.1021/acs.jmedchem.4c01533. Epub 2024 Nov 15.
2
Design, Synthesis, and Evaluation of Dihydropyrimidine Derivatives as Selective PDE1 Inhibitors for the Treatment of Liver Fibrosis.设计、合成并评价嘧啶二酮衍生物作为治疗肝纤维化的选择性 PDE1 抑制剂。
J Med Chem. 2024 May 23;67(10):8309-8322. doi: 10.1021/acs.jmedchem.4c00461. Epub 2024 Apr 26.
3
Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis.发现新型选择性和口服生物可利用的磷酸二酯酶-1 抑制剂,用于有效治疗特发性肺纤维化。
J Med Chem. 2020 Jul 23;63(14):7867-7879. doi: 10.1021/acs.jmedchem.0c00711. Epub 2020 Jun 30.
4
Design, synthesis, and evaluation of quinolin-2(1H)-ones as PDE1 inhibitors for the treatment of inflammatory bowel disease.喹啉-2(1H)-酮作为治疗炎症性肠病的磷酸二酯酶1抑制剂的设计、合成与评价
Bioorg Chem. 2025 Jan;154:107979. doi: 10.1016/j.bioorg.2024.107979. Epub 2024 Nov 19.
5
Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.结构修饰尼莫地平得到新型 PDE1 抑制剂抗肺纤维化作用。
J Med Chem. 2022 Jun 23;65(12):8444-8455. doi: 10.1021/acs.jmedchem.2c00458. Epub 2022 Jun 6.
6
Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.多环吡唑并[3,4-d]嘧啶作为PDE1和PDE5 cGMP磷酸二酯酶抑制剂的合成与评价
J Med Chem. 1997 Dec 19;40(26):4372-7. doi: 10.1021/jm970495b.
7
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1.发现强效和选择性外周受限的环核苷酸磷酸二酯酶 PDE1 的喹唑啉抑制剂。
J Med Chem. 2018 May 24;61(10):4635-4640. doi: 10.1021/acs.jmedchem.8b00374. Epub 2018 May 10.
8
Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors.新型吡唑并嘧啶酮衍生物的设计、合成及作为强效 PDE1 抑制剂的生物评价。
Bioorg Chem. 2021 Sep;114:105104. doi: 10.1016/j.bioorg.2021.105104. Epub 2021 Jun 18.
9
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.发现用于治疗与神经退行性疾病和神经精神疾病相关的认知障碍的强效且选择性的磷酸二酯酶1抑制剂。
J Med Chem. 2016 Feb 11;59(3):1149-64. doi: 10.1021/acs.jmedchem.5b01751. Epub 2016 Feb 2.
10
Enhanced sampling simulations to explore himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders.增强采样模拟以探索喜马拉雅植物化学物质作为神经疾病潜在磷酸二酯酶-1抑制剂。
Biochem Biophys Res Commun. 2025 Apr 12;758:151614. doi: 10.1016/j.bbrc.2025.151614. Epub 2025 Mar 11.

引用本文的文献

1
Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket.分子动力学辅助发现靶向独特变构口袋的新型磷酸二酯酶-5抑制剂
Molecules. 2025 Jan 27;30(3):588. doi: 10.3390/molecules30030588.